drugset / Trial / NCT01442987
Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of coadministered Irbesartan and Atorvastatin in patients with hypertension and hyperlipidemia.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-04
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 40 mg | Oral |
| Comparator | Atorvastatin | Small molecule | 80 mg | Oral |
| Subject | Irbesartan | Small molecule | 300 mg | Oral |